Small molecule drug companies develop low-molecular-weight medicines designed to interact with specific biological targets. These compounds can often enter cells and may be formulated as oral or other conventional dosage forms across a wide range of therapeutic areas.
This category includes companies working on:
Browse 202 UK small molecule drug companies below.
Hydrogel capsule platform for weight loss and oral drug delivery
Oxford Medical Products is developing a gastroretentive hydrogel platform with two applications. The technology is a swallowable dual-polymer capsule that expands in the stomach…
Bioanalytical and toxicology laboratory for pharmaceutical and clinical research
Analytical Services International is a GLP and GCP-compliant bioanalytical laboratory providing mass spectrometry-based services to pharmaceutical companies and contract research…
Small molecule remyelination therapeutics for neurological diseases
Pheno Therapeutics is a Scottish clinical-stage biotechnology company developing small molecule therapeutics that promote remyelination by boosting the function of…
Precision oncology biotech targeting novel DNA damage response pathways
Nodus Oncology is a preclinical-stage biotechnology company developing small molecule inhibitors against novel DNA damage response targets for molecularly defined cancer patient…
Generic injectable medicines for NHS secondary care
Bowmed Ibisqus is a privately owned pharmaceutical company supplying generic injectable medicines to NHS hospitals and the private healthcare sector. Operating as a marketing…
Small molecule drug discovery focused on fibrosis and oncology
Redx Pharma is a clinical-stage biotech developing novel small molecule therapeutics for fibrotic disease and cancer. Its pipeline is anchored by zelasudil, a selective ROCK2…
AI-driven drug discovery targeting intrinsically disordered proteins
Peptone is a translational biophysics company developing novel therapeutics against intrinsically disordered proteins (IDPs), a class of structurally dynamic proteins implicated…
GPCR-targeted small molecule therapeutics
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate G protein-coupled…
Bioanalytical, DMPK and analytical sciences CRO for drug development
Resolian UK is a contract research organisation specialising in bioanalysis, drug metabolism and pharmacokinetics, and analytical sciences services for pharmaceutical and…
Emergency treatment for anticoagulant-associated intracranial haemorrhage
Alveron Pharma is a clinical-stage biotechnology company developing OKL-1111, a novel drug candidate for the emergency treatment of intracranial haemorrhage and other severe…
AI-driven target identification and drug discovery from omics data
Intelligent OMICS is a biotechnology company applying artificial intelligence and machine learning to drug discovery and diagnostics. Its proprietary platform analyses…
Small molecule drug discovery platform focused on immuno-inflammation
C4X Discovery (C4XD) is a UK drug discovery company developing small molecule drug candidates using its proprietary computational and structural chemistry platform. It applies…